Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study
Sohier Yahia1, Reham M El-Farahaty, Amany K El-Hawary
1Department of Pediatrics, Faculty of Medicine, Mansoura University Children Hospital, Mansoura, Egypt. amany.hawary.hawary10@gmail.com.
Insights
Obese children with Down syndrome (DS) show elevated fasting glucose and insulin, indicating early insulin resistance. While leptin resistance is similar to simple obesity, myopathy may contribute to obesity in DS.
Area of Science:
- Endocrinology
- Pediatrics
- Genetics
Background:
- Obesity is more prevalent in individuals with Down syndrome (DS) compared to the general population.
- The underlying reasons for the increased obesity risk in DS remain unclear.
- This study investigates obesity-related hormones in prepubertal children with DS.
Purpose of the Study:
- To clarify differences in obesity-related hormones between children with and without Down syndrome.
- To assess insulin resistance and leptin resistance in obese children with Down syndrome.
- To explore potential contributing factors to obesity in Down syndrome.
Main Methods:
- Compared 36 Egyptian children with DS (23 obese, 13 non-obese) to 43 non-DS children (20 obese, 23 non-obese).
- Measured fasting blood glucose (FBG), insulin, leptin, free thyroxin (FT4), thyroid stimulating hormone (TSH), and creatine kinase (CK).
- Assessed insulin resistance using HOMA-IR and leptin resistance using the leptin to BMI ratio (LEP/BMI).
Main Results:
- Median FBG, insulin, and HOMA-IR were significantly higher in the DS group.
- Leptin and leptin resistance showed no significant difference between DS and non-DS groups.
- Four cases of subclinical hypothyroidism were identified in the DS group; leptin correlated with insulin and IR, but not TSH.
Conclusions:
- Obese children with Down syndrome exhibit similar leptin resistance to those with simple obesity.
- Elevated FBG and insulin in obese DS children suggest early insulin resistance.
- Mildly elevated creatine kinase (CK) levels indicate associated myopathy, potentially contributing to obesity in this population.
Background:
Obesity is a major worldwide health problem. It is commonly observed in Down syndrome individuals than in the general population. The reason for increased risk of obesity in DS is unclear.The current study was designed to clarify differences in some obesity- related hormones in a group of prepubertal Down syndrome children.
Methods:
Thirty six Egyptian children with Down syndrome were enrolled in this study, divided according to their body mass index (BMI) into 23 obese and13 non obese. Another group of 43 non Down children were recruited, they were divided according to their BMI into 20 patients having simple obesity and 23 non obese, as control groups. Fasting blood samples were collected for estimation of fasting blood glucose (FBG), insulin, leptin, free thyroxin (FT4), thyroid stimulating hormones (TSH) and creatine kinase (CK). Insulin resistance was assessed by Homeostasis Model Assessment method (HOMA-IR). The ratio of leptin to BMI (LEP/BMI) was used as an index of leptin resistance.
Results:
Median values of FBG, insulin, and HOMA-IR were significantly higher in Down versus non Down groups, while median values of leptin and leptin resistance were non-significantly different among Down versus non Down groups. Median TSH values were non- significantly different between obese Down and obese non Down. Although the median values of TSH and FT4 were within normal range in Down groups, four cases of subclinical hypothyroidism were encountered. Leptin levels were correlated with insulin and IR but not with TSH in Down groups.
Conclusion:
Increased circulating leptin, a marker of leptin resistance in obese children with Down syndrome seems to be similar to that in children with simple obesity. Elevated FBG and insulin in obese Down children highlights the presence of early IR. Associated myopathy evidenced by mildly elevated CK levels could be an added factor for obesity in such group of patients.
Related Concept Videos
Obesity
Hypoglycemia
Hyperthyroidism I: Introduction
Type II Diabetes II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion


